SYNCONA PORTFOLIO LTD
Foreign holder
15 UK shareholdings·2 ownership layers
SYNCONA PORTFOLIO LTD is a corporate shareholder registered in GUERNSEY and holds shares in 15 active UK companies, recorded across 35 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 5 companies spanning 2 ownership layers, of which 12 direct holdings are themselves holding companies; the persons-with-significant-control register independently agrees on 3 of these holdings. It ranks #688 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.
Holdings that are holding companies
12
PSC register agrees on
3 holdings
Company profile
SYNCONA PORTFOLIO LTD is a GUERNSEY entity; OpenRegistry holds no UK register profile for it.
Shareholdings
Every company SYNCONA PORTFOLIO LTD appears on as a member, as filed. 15 of 15 are linked to their Companies House profile.
| Company held | Status | Accounts | Share class | Shares | % of class | % of capital | Total % of capital | As of |
|---|
| SLINGSHOT THERAPEUTICS HOLDINGS LIMITED ▼15871470 | Active | SMALL | ORDINARY | 5,601,000 | 100.00% | 100.00% | 100.00% | 2025-08-01 |
| MOSAIC THERAPEUTICS LIMITED12780154 | Active | SMALL | SERIES A2 PREFERRED | 36,400,000 | 76.67% | 58.39% | 70.16% | 2025-07-29 |
| SERIES A1 PREFERRED | 7,333,333 | 100.00% | 11.76% |
| KESMALEA THERAPEUTICS LIMITED12961631 | Active | SMALL | SERIES A PREFERRED | 20,000,000 | 80.00% | 61.13% | 61.13% | 2025-10-19 |
| RE-AIM THERAPEUTICS LTD15689618 | Active | SMALL | SERIES SEED | 138,461 | 64.29% | 42.05% | 42.05% | 2026-04-28 |
| QUELL THERAPEUTICS LIMITED11890040 | Active | FULL | SERIES A PREFERRED | 45,171,429 | 97.14% | 27.18% | 35.13% | 2026-04-28 |
| SERIES B PREFERRED | 13,227,513 | 13.96% | 7.96% |
| OMASS THERAPEUTICS LIMITED10028228 | Active | FULL | SERIES A | 20,299,496 | 63.59% | 22.52% | 32.25% | 2026-03-12 |
| SERIES B | 8,771,929 | 17.54% | 9.73% |
| BIOMODAL LIMITED08005377 | Active | GROUP | ORDINARY | 766,729 | 20.68% | 2.86% | 2.86% | 2026-03-26 |
| SWANBIO THERAPEUTICS LIMITED10942620 | Active | TOTAL EXEMPTION FULL | SERIES A PREFERRED | 0 | | | | 2024-08-31 |
| SERIES B PREFERRED | 0 | | |
| RESOLUTION THERAPEUTICS LIMITED11112568 | Active | GROUP | SERIES B (T1) | 25,648,668 | | | | 2026-01-31 |
| SERIES A PREFERRED | 37,942,026 | | |
| SERIES B (T2) | 31,280,716 | | |
| PURESPRING THERAPEUTICS LIMITED12543677 | Active | SMALL | SERIES B1 | 10,805,675 | | | | 2026-03-31 |
| SERIES B2 | 24,843,892 | | |
| DEFERRED | 100 | | |
| SERIES A PREFERRED | 35,100,000 | | |
| FORCEFIELD THERAPEUTICS LIMITED12983133 | Active | SMALL | SERIES SEED PREFERRED | 5,500,000 | | | | 2025-10-21 |
| DEFERRED | 100 | | |
| SERIES A1 PREFERRED | 1,839,081 | | |
| GYROSCOPE THERAPEUTICS HOLDINGS LIMITED ▼13086765 | Active | DORMANT | SERIES C2 PREFERRED | 0 | | | | 2022-12-16 |
| B ORDINARY | 0 | | |
| SERIES A PREFERRED | 0 | | |
| SERIES B PREFERRED | 0 | | |
| SERIES C1 PREFERRED | 0 | | |
| BEACON THERAPEUTICS HOLDINGS LIMITED ▼14303840 | Active | GROUP | SERIES B1 PREFERRED | 11,138,143 | | | | 2025-08-17 |
| ORDINARY | 8,000,000 | | |
| SERIES A PREFERRED | 75,000,000 | | |
| SERIES B2 PREFERRED | 10,676,987 | | |
| YELLOWSTONE BIOSCIENCES LIMITED14606478 | Active | SMALL | SERIES A | 16,500,000 | | | | 2025-01-19 |
| ORDINARY | 900,000 | | |
| SPUR THERAPEUTICS HOLDINGS LIMITED ▼15295548 | Active | GROUP | SERIES B PREFERRED | 79,608,244 | | | | 2025-11-19 |
| SERIES A PREFERRED | 116,385,757 | | |
Ownership structure below these holdings
5 further companies sit beneath this entity’s direct holdings, across 2 layers. Each is linked to its Companies House profile.
Related company owners
Corporate shareholders that hold shares in the same UK companies as SYNCONA PORTFOLIO LTD:
Other corporate shareholders of comparable size registered in GUERNSEY: